Childress Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $413K | Sell |
1,018
-374
| -27% | -$152K | 0.1% | 143 |
|
|
2025
Q1 | $693K | Buy |
1,392
+69
| +5% | +$34.3K | 0.2% | 72 |
|
|
2024
Q4 | $688K | Sell |
1,323
-106
| -7% | -$55.2K | 0.19% | 73 |
|
|
2024
Q3 | $884K | Sell |
1,429
-7
| -0.5% | -$4.33K | 0.24% | 68 |
|
|
2024
Q2 | $794K | Buy |
+1,436
| New | +$794K | 0.22% | 70 |
|
|
2024
Q1 | – | Sell |
-1,479
| Closed | -$785K | – | 217 |
|
|
2023
Q4 | $785K | Sell |
1,479
-193
| -12% | -$102K | 0.23% | 64 |
|
|
2023
Q3 | $846K | Buy |
+1,672
| New | +$846K | 0.28% | 59 |
|
|
2023
Q1 | – | Sell |
-1,791
| Closed | -$986K | – | 168 |
|
|
2022
Q4 | $986K | Sell |
1,791
-357
| -17% | -$197K | 0.33% | 54 |
|
|
2022
Q3 | $1.1M | Buy |
2,148
+22
| +1% | +$11.2K | 0.43% | 45 |
|
|
2022
Q2 | $1.16M | Buy |
2,126
+148
| +7% | +$80.4K | 0.46% | 41 |
|
|
2022
Q1 | $1.17M | Buy |
1,978
+166
| +9% | +$97.9K | 0.41% | 46 |
|
|
2021
Q4 | $1.21M | Sell |
1,812
-18
| -1% | -$12K | 0.5% | 41 |
|
|
2021
Q3 | $1.05M | Buy |
1,830
+221
| +14% | +$126K | 0.42% | 49 |
|
|
2021
Q2 | $811K | Sell |
1,609
-24
| -1% | -$12.1K | 0.37% | 49 |
|
|
2021
Q1 | $745K | Buy |
1,633
+345
| +27% | +$157K | 0.34% | 55 |
|
|
2020
Q4 | $600K | Buy |
+1,288
| New | +$600K | 0.35% | 36 |
|